Abstract:Background & Aims: The pathogenesis of hypertension involves a diverse range of genetic, environmental, hemodynamic, and more causative factors. Recent evidence points to an association between the gut microbiome and hypertension. Given that the microbiota is in part determined by host genetics, we used the two-sample Mendelian randomization (MR) analysis to address the bidirectional causal link between gut microbiota and hypertension. Methods: We selected genetic variants ( P < 1 × 10 −5 ) for gut microbiota ( n = 18,340) from the MiBioGen study. Genetic association estimates for hypertension were extracted from genome-wide association study (GWAS) summary statistics on 54,358 cases and 408,652 controls. Seven complementary MR methods were implemented, including the inverse-variance weighted (IVW) method, followed by sensitivity analyses to verify the robustness of the results. Reverse-direction MR analyses were further conducted to probe if there was a reverse causative relationship. Bidirectional MR analysis then examines a modulation of gut microbiota composition by hypertension. Results: At the genus level, our MR estimates from gut microbiome to hypertension showed that there were 5 protective factors Allisonella , Parabacteroide , Phascolarctobacterium , Senegalimassilia, and unknowngenus (id.1000000073), while 6 genera Clostridiuminnocuum , Eubacteriumcoprostanoligenes , Eubacteriumfissicatena , Anaerostipes , LachnospiraceaeFCS020 , and unknowngenus (id.2041) are risk factors. The Alcaligenaceae and ClostridialesvadinBB60 were detrimental and beneficial at the family level, respectively. In contrast, the MR results of hypertension-gut flora showed hypertensive states can lead to an increased abundance of E ubacteriumxylanophilum , Eisenbergiella , and Lachnospiraceae and a lower abundance of Alistipes , Bilophila , Butyricimonas , and Phascolarctobacterium . Conclusion: Altered gut microbiota is a causal factor in the development of hypertension, and hypertension causes imbalances in the intestinal flora. Substantial research is still needed to find the key gut flora and explore the specific mechanisms of their effects so that new biomarkers can be found for blood pressure control.

Gut microbiota and hypertensive disorders in pregnancy: evidence from the mendelian randomization study

Longitudinal change of gut microbiota in hypertensive disorders in pregnancy: a nested case–control and Mendelian randomization study

Investigating causal associations among gut microbiota, gut microbiota-derived metabolites, and gestational diabetes mellitus: a bidirectional Mendelian randomization study

Exploring genetic associations between immune cells and hypertensive disorder of pregnancy using Mendelian randomization

Causal association between gut microbiota and hyperemesis gravidarum: a two-sample Mendelian randomization study

Causality of gut microbiome and hypertension: A bidirectional mendelian randomization study

The Causality between Gut Microbiota and Hypertension and Hypertension-related Complications: A Bidirectional Two-Sample Mendelian Randomization Analysis

Genetically predicted circulating concentrations of micronutrients and risk of hypertensive disorders of pregnancy: a Mendelian randomization study

Causal Associations Between the Gut Microbiota and Hypertension‐Related Traits Through Mendelian Randomization: A Cross‐Sectional Cohort Study

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Causal effects of gut microbiome on hypertension: a Mendelian randomization study

Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Causal associations between gut microbiota and adverse pregnancy outcomes: A two-sample Mendelian randomization study

Association between gut microbiota and menstrual disorders: a two-sample Mendelian randomization study

Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study

Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

Gut microbiota and functional dyspepsia: a two-sample Mendelian randomization study

Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study

Circulating inflammatory cytokines and hypertensive disorders of pregnancy: a two-sample Mendelian randomization study

Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study